422
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Sustainability of vaginal estrogens for genitourinary syndrome of menopause – a systematic review

, , ORCID Icon, &
Pages 551-559 | Received 27 Sep 2020, Accepted 10 Feb 2021, Published online: 12 Mar 2021

References

  • Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21:1063–1068.
  • Kim H-K, Kang S-Y, Chung Y-J, et al. The recent review of the genitourinary syndrome of menopause. J Menopausal Med. 2015;21:65–71.
  • Krychman M, Graham S, Bernick B, et al. The women's EMPOWER survey: women's knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14:425–433.
  • Huang AJ, Gregorich SE, Kuppermann M, et al. Day-to-day impact of vaginal aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause. 2015;22:144–154.
  • Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67:233–238.
  • Moyneur E, Dea K, Derogatis LR, et al. Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareunia. Menopause. 2020;27:134–142.
  • The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27:976–992.
  • Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;(8):CD001500.
  • Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010;17:25–54.
  • Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015;18:757–763.
  • Caruso S, Cianci A, Sarpietro G, et al. Ultralow 0.03 mg vaginal estriol in postmenopausal women who underwent surgical treatment for stress urinary incontinence: effects on quality of life and sexual function. Menopause. 2020;27:162–169.
  • Gaspar A, Brandi H, Gomez V, et al. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. 2017;49:160–168.
  • Smith P. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring. Acta Obstet Gynecol Scand. 1993;72:5–26.
  • Felding C, Mikkelsen AL, Clausen HV, et al. Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse. A randomised, double-blind trial. Maturitas. 1992;15:241–249.
  • Dyer GI, Young O, Townsend PT, et al. Dose-related changes in vaginal cytology after topical conjugated equine oestrogens. Br Med J (Clin Res Ed). 1982;284:789.
  • Abdelbary AM, El-Dessoukey AA, Massoud AM, et al. Combined vaginal pelvic floor electrical stimulation (PFS) and local vaginal estrogen for treatment of overactive bladder (OAB) in perimenopausal females. Randomized Controlled Trial (RCT). Urology. 2015;86:482–486.
  • Maloney C, Oliver ML. Effect of local conjugated estrogens on vaginal pH in elderly women. J Am Med Dir Assoc. 2001;2:51–55.
  • Gordon WE, Hermann HW, Hunter DC. Treatment of atrophic vaginitis in postmenopausal women with micronized estradiol cream–a follow-up study. J Ky Med Assoc. 1979;77:337–339.
  • Nachtigall LE. Comparative study: replens versus local estrogen in menopausal women. Fertil Steril. 1994;61:178–180.
  • Weissmann-Brenner A, Bayevsky T, Yoles I. Compliance to vaginal treatment-tablets versus cream: a retrospective 9 years study. Menopause. 2017;24:73–76.
  • Shulman LP, Portman DJ, Lee WC, et al. A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice. J Womens Health (Larchmt). 2008;17:569–578.
  • Williamson PR, Altman DG, Bagley H, et al. The COMET Handbook: version 1.0. Trials. 2017;18:280.
  • Hickey, M. COMMA (core Outcomes in Menopause): international collaboration to measure core outcomes in menopause; 2016. Available from: http://www.comet-initiative.org/studies/details/917.
  • Smith P, Heimer G, Lindskog M, Ulmsten U. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 1993;16:145–154.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.